Tesamorelin: The GHRH Analog for Visceral Fat, Explained

A growth-hormone-releasing peptide with a very specific research focus.

Published by Peptide Protocols · Reviewed September 2026 · How we make these pages · Educational & research purposes only — not medical advice.

Among the growth-hormone-releasing peptides, tesamorelin stands out because it has an actual approved medical use and a very specific research reputation: reducing visceral (deep belly) fat.

What tesamorelin is

Tesamorelin is a GHRH analog — a stabilized version of growth-hormone-releasing hormone. Instead of adding growth hormone directly, it nudges the pituitary to release the body's own GH in a more natural, pulsing pattern. It is FDA-approved under the brand Egrifta for a specific condition (HIV-associated lipodystrophy, an abnormal fat distribution), which is why it's better characterized than many peptides in this space.

Why people research it beyond that use: its signature effect — lowering visceral fat specifically — is the reason it draws interest in the broader metabolic and longevity research conversation.

How it compares to sermorelin and ipamorelin

For the side-by-side, see sermorelin vs ipamorelin and our growth-hormone peptides overview.

The honest caution

Approved for one thing ≠ a green light for everything. Tesamorelin's approval is narrow and specific. Anything outside that is off-label or research territory, and growth-hormone signaling has real considerations. This is educational only, not medical advice.

🧮 Do the reconstitution math in seconds

Vial mg + bacteriostatic water mL + your target mcg → mL and U-100 syringe units, instantly. Free, no sign-up, 60+ research peptides preset — plus dedicated calculators and BAC-water charts for BPC-157, retatrutide, tirzepatide, semaglutide, tesamorelin and CJC-1295/ipamorelin.

Open the free peptide calculator →

Research & educational use only — never medical advice.

Vet the supplier yourself

We do not recommend or partner with any peptide supplier. Use the checklist instead: third-party COAs that match your batch and lot, stated purity, clear research-use labeling, real support and proper cold-chain shipping.

The supplier checklist →

Educational content only. Confirm the legal status where you live before ordering anything.

Quick FAQ

What is tesamorelin used for?

It's FDA-approved (as Egrifta) for HIV-associated lipodystrophy. Its signature research reputation is reducing visceral (deep abdominal) fat, which is why it draws broader metabolic interest.

Does tesamorelin build muscle?

It works by prompting the body's own growth-hormone release rather than adding GH directly; muscle effects aren't its defining feature — visceral-fat reduction is. Treat non-approved uses as research, not established.

Tesamorelin vs sermorelin — what's the difference?

Both are GHRH-based, but tesamorelin is a stabilized analog with an approved use and the visceral-fat reputation, while sermorelin is an older, shorter-acting fragment used more generally.

Keep reading

Understand the GH peptides side by side

Our guides lay out the growth-hormone-releasing peptides — what each does, the timing, and the reconstitution math — without the hype.

Browse the shop on Etsy →
Free · Instant · Plain-English
Get the free Reconstitution Cheat Sheet

The one formula, a BAC-water chart, and the 10 most-researched beginner peptides — the math done for you. Print it for the fridge.

🎁 Send me the free cheat sheet →

Related guides